1. 69 Afatinib versus gefitinib as first-line treatment for patients with advanced non-small-cell lung cancer (NSCLC) harbouring activating EGFR mutations: results of the global, randomised, open-label, phase IIb trial LUX-Lung 7. (January 2016) Authors: O'Byrne, K.J.; Park, K.; Tan, E.; Zhang, L.; Hirsh, V.; Boyer, M.; Yang, J.C.; Mok, T.; Kim, M.; Massey, D.; Zazulina, V.; Paz-Ares, L. Journal: Lung cancer Issue: Volume 91(2016)Supplement 1 Page Start: S25 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Calibration method of meteorological sensor based on enhanced BP network. (1st October 2020) Authors: Wang, Y.M.; Jia, K.B.; Liu, P.Y.; Zhang, W.J.; Yang, J.C. Journal: Journal of instrumentation Issue: Volume 15:Number 10(2020) Page Start: P10014 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Collective effects near transition energy in the proton mode of HIAF/BRing. (1st December 2020) Authors: Cai, F.C.; Yang, J.C.; Liu, J.; Shen, G.D.; Chen, X.Q.; Xu, Z.; Yin, D.Y.; Cong, Y.; Jin, P.; Zhu, G.Y.; Xia, J.W.; Xu, H.S.; Zhao, H.W.; Yuan, Y.J.; Zhan, W.L.; Zhou, X.H. Journal: Journal of instrumentation Issue: Volume 15:Number 12(2020) Page Start: P12035 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Device processing and junction formation needs for ultra-high power Ga2O3 electronics. (29th January 2019) Authors: Ren, Fan; Yang, J.C.; Fares, Chaker; Pearton, S.J. Journal: MRS communications Issue: Volume 9:Number 1(2019) Page Start: 77 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. DOSE AND/OR VOLUME REDUCTION USING CONSOLIDATION VOLUME RADIATION THERAPY (CVRT) LOWERS DOSE TO HEART AND LUNGS IN EARLY‐STAGE HODGKIN LYMPHOMA PATIENTS WITH BULKY DISEASE. (June 2017) Authors: Yang, J.C.; Kumar, A.; Chapman, K.L.; Burleson, S.; Huang, C.; Constine, L.S.; Hoppe, R.T.; Dandapani, S.; Straus, D.J.; Moskowitz, C.H.; Yahalom, J. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 175 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. HIGHLY FAVORABLE OUTCOMES WITH RT FOLLOWED BY ASCT IN LOW/LOW‐INTERMEDIATE SECONDARY AGE ADJUSTED IPI REL/REF DLBCL PATIENTS REFRACTORY TO SALVAGE CHEMOTHERAPY. (12th June 2019) Authors: Yang, J.C.; Chau, K.W.; Scordo, M.; Sauter, C.S.; Yahalom, J. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 261 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Impact of interpersonal relationships and acquired capability for suicide on suicide attempts: An observational study. (1st June 2022) Authors: Shim, S.H.; Yang, J.C.; Hahn, S.W.; Kim, J.S.; Yoon, S.H. Journal: European psychiatry Issue: Volume 65:Supplement 1(2022) Page Start: S834 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Introduction of the Heavy Ion Research Facility in Lanzhou (HIRFL). (1st December 2020) Authors: Mao, L.J.; Yang, J.C.; Yang, W.Q.; Xia, J.W.; Yuan, Y.J.; Yuan, P.; Qiao, W.M.; Gao, D.Q.; Xiao, G.Q.; Zhao, H.W.; Xu, H.S.; Song, M.T.; Yang, X.D.; Cai, X.H.; Ma, L.Z.; Yang, X.T.; Man, K.T.; He, Y.; Zhou, Z.Z.; Zhang, J.H. Journal: Journal of instrumentation Issue: Volume 15:Number 12(2020) Page Start: T12015 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. OUTCOMES OF 180 PATIENTS WITH INDOLENT LYMPHOMAS TREATED WITH VERY LOW DOSE (4 GY) RADIATION THERAPY ALONE. (12th June 2019) Authors: Chau, K.W.; Imber, B.S.; Joffe, E.; Yang, J.C.; Chelius, M.R.; Doyle, C.J.; Hajj, C.; Yahalom, J. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 222 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Phase 2 study of lenvatinib in patients with RET fusion-positive adenocarcinoma of the lung. (February 2017) Authors: Velcheti, V.; Hida, T.; Reckamp, K.L.; Yang, J.C.; Nokihara, H.; Sachdev, P.; Feit, K.; Kubota, T.; Nakada, T.; Dutcus, C.E.; Ren, M.; Tamura, T. Journal: European journal of cancer Issue: Volume 72(2017)Supplement 1 Page Start: S178 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗